LAMBERTUCCI, Catia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.038
EU - Europa 4.243
AS - Asia 1.690
Continente sconosciuto - Info sul continente non disponibili 33
SA - Sud America 13
AF - Africa 7
OC - Oceania 6
Totale 16.030
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.723
CN - Cina 1.403
PL - Polonia 1.254
IT - Italia 857
DE - Germania 529
UA - Ucraina 385
GB - Regno Unito 326
SE - Svezia 319
CA - Canada 313
FR - Francia 210
FI - Finlandia 171
SG - Singapore 165
IE - Irlanda 86
EU - Europa 33
BE - Belgio 29
VN - Vietnam 26
KR - Corea 25
CZ - Repubblica Ceca 18
IN - India 15
NL - Olanda 15
IR - Iran 12
RO - Romania 12
HK - Hong Kong 11
TR - Turchia 9
RU - Federazione Russa 8
AT - Austria 7
BR - Brasile 7
JP - Giappone 6
AU - Australia 5
DK - Danimarca 4
LB - Libano 4
GR - Grecia 3
TW - Taiwan 3
DZ - Algeria 2
ES - Italia 2
JO - Giordania 2
TH - Thailandia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
BT - Bhutan 1
CH - Svizzera 1
CL - Cile 1
CM - Camerun 1
CO - Colombia 1
EC - Ecuador 1
ID - Indonesia 1
KE - Kenya 1
MD - Moldavia 1
MT - Malta 1
MX - Messico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 16.030
Salva come PNG Salva come JPEG
Città #
Fairfield 1.292
Woodbridge 1.111
Warsaw 1.098
Jacksonville 954
Chandler 752
Houston 674
Ashburn 652
Seattle 564
Wilmington 514
Ann Arbor 481
Cambridge 440
Nanjing 312
Toronto 228
Camerino 183
Kraków 152
San Mateo 141
Boardman 137
Dearborn 134
Lawrence 132
Princeton 132
Beijing 131
Ogden 107
Columbus 104
Nanchang 102
Düsseldorf 99
Singapore 93
Dublin 85
Lachine 82
Helsinki 74
London 69
Shanghai 66
San Diego 63
Kunming 62
Shenyang 62
New York 58
Tianjin 52
Milan 51
Guangzhou 49
Hebei 42
Jiaxing 42
Centro 38
Brussels 29
Los Angeles 29
Ningbo 29
Jinan 25
Changsha 24
Chicago 24
Dong Ket 23
Wuhan 23
Hangzhou 22
Hefei 22
Norwalk 22
Falls Church 20
Orange 20
Verona 20
Jinhua 19
Redwood City 19
Bremen 18
Philadelphia 18
Zhengzhou 18
Venezia 17
Brno 15
Munich 14
Tappahannock 13
Detroit 12
Nürnberg 12
San Francisco 12
Taizhou 11
Yiwu 11
Hounslow 10
Indiana 10
New Bedfont 10
Washington 10
Acton 9
Changchun 9
Leawood 9
Perugia 9
Auburn Hills 8
Kilburn 8
Meppel 8
Scafati 8
Seoul 8
Ardabil 7
Buffalo 7
Frankfurt am Main 7
Kocaeli 7
Lanzhou 7
Rome 7
Scuola 7
Shenzhen 7
Ascoli Piceno 6
Caserta 6
Chengdu 6
Council Bluffs 6
Horia 6
Varese 6
Alessandria 5
Ancona 5
Chiswick 5
Fuzhou 5
Totale 12.383
Salva come PNG Salva come JPEG
Nome #
The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor 326
Overview on Radiolabel-Free in Vitro Assays for GPCRs 313
A2AR agonists/A3R antagonists: design, synthesis, and biological evaluation of new ligands with dual activity 265
2′,3′-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 260
Pharmacological characterization of the GPR17 receptor dual profile 251
2’,3’-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 249
The G Protein-Coupled Receptor GPR17: Overview and Update 246
Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia 208
Adenine based acyclic-nucleotides as novel P2X3 receptor ligands 207
8-(2-Furyl)adenine derivatives as A2A adenosine receptor ligands 205
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists 197
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor 192
GPR17 receptor modulators and their therapeutic implications: review of recent patents 184
Human cytidine deaminase: understanding the catalytic mechanism 180
Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists 177
Neuropeptide S Receptor: recent updates on non-peptide antagonist discovery 174
Approaches for designing and discovering purinergic drugs for gastrointestinal diseases 174
Antiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines 167
Purine and deazapurine nucleosides: synthetic approaches, molecular modeling and biological activity 165
Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs 165
Levels of polychlorinated biphenyls in fish and shellfish from the Adriatic Sea 161
3'-Deoxyribofuranose derivatives of 1-deaza and 3-deaza adenosine and their activity as adenosine deaminase inhibitors 156
Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A2A adenosine receptor binding site 156
Ex-vivo absorption study of lysine R-lipoate salt, a new pharmaceutical form of R-ALA 156
Synthesis of a conformationally restricted analogue of paclitaxel 155
New sensible method to quantize the intestinal absorption of receptor ligands 155
“Third Joint Italian-German Purine Club Meeting - Purinergic Receptors: New Frontiers for Novel Therapies” 154
Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases 154
Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1 152
Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family 151
9-ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities 151
Adenine and deazaadenine nucleoside and deoxynucleoside analogues: inhibition of viral replication of sheep MVV (in vitro model for HIV) and bovine BHV-1 150
Evidence for the existence of a specific G protein-coupled receptor activated by guanosine 149
New substituted 9-propyladenine derivatives as A2Aadenosine receptor antagonists 148
Biomarkers Mapping in a Neuropathic Pain Mice Model with Sciatic Nerve Chronic Constriction Injury (CCI). 148
Adenosine deaminase: Functional implications and different classes of inhibitors 147
A taxane epoxide from taxus wallichiana 147
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors 147
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview 147
Biomarkers mapping of neuropathic pain in a nerve chronic constriction injury mice model 146
Molecular modeling studies on the human neuropeptide S receptor and its antagonists. 145
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. 145
Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17 145
Molecular modeling study on potent and selective adenosine A3 receptor agonists. 145
Synthesis and NMR-Driven Conformational Analysis of Taxol Analogues Conformationally Constrained on the C13 Side Chain 144
Purinergic P2X receptors: Structural models and analysis of ligand-target interaction 144
The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors 143
Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor 143
The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2B receptor 143
Solid phase synthesis and antiprotozoal evaluation of di- and trisubstituted 5 '-carboxamidoadenosine analogues 143
Identification of alpha(1)-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens 142
Ring opening reactions: synthesis of AICAR analogs as potential antimetabolite agents 142
GPCRs as therapeutic targets: a view on adenosine receptors structure and functions, and molecular modeling support 140
Pharmacological postconditioning of the rabbit heart with non-selective, A1, A2A and A3 adenosine receptor agonists 138
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications 138
Synthesis and evaluation of hexitol nucleoside congeners as ambiguous nucleosides 137
Introduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A(3) adenosine receptor 137
Coupling of 2,6-disubstituted purines to ribose-modified sugars 136
Antiviral properties of deazaadenine nucleoside derivatives 136
Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch 135
Adenosine receptor modeling: what does the A2A crystal structure tell us? 133
Synthesis, structure-affinity relationships and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists 130
8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A(2A) and A(2B) receptors ligands 130
New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile 129
Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists. Synthesis, structure-affinity relationships and molecular modeling studies 129
Synthesis and adenosine receptor affinity and potency of 8-alkynyl derivatives of adenosine 127
A(2A) Adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists 126
Synthesis and stability studies of 2 ',3 ',5 '-tri-O-acetyl-2-amino(-N-6-cyclopentyl)-1-deazaadenosines 126
Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists 125
Effects of 5 '-phosphate derivatives of 2-hexynyl adenosine and 2-phenylethynyl adenosine on responses of human platelets mediated by P2Y receptors 120
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists 118
Probing ambiguous base-pairs by genetic transformation with XNA templates 118
2- And 8- alkynyladenosines: conformational studies and docking to human adenosine A(3) receptor can explain their different biological behavior 114
Human adenosine A3 receptor as selective target of new 2-aralkynyl-N6-methyl-MECA derivatives 113
The Chemistry and Occurrence of Taxane Derivatives. XXVI. A Reactivity Study on 11(15→1)Abeotaxanes 110
2-substituted 5 '-N-methylcarboxamidoadenosine (MECA) derivatives as A(3) adenosine receptor ligands 110
Synthesis of new nucleosides by coupling of chloropurines with 2- and 3-deoxy derivatives of N-methyl-D-ribofuranuronamide 109
A(2A) adenosine receptor agonists reduce both high-palatability and low-palatability food intake in female rats 105
The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis 105
Adenosine A(2A) receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease 104
N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A(3) adenosine receptor 103
N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands 103
Innovative functional cAMP assay: application to the pharmacological characterization of GPR17 103
A(2B) adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyladenosine and NECA derivatives 102
Adenosine receptor agonists:synthesis and binding affinity of 2-(aryl)alkylthioadenosine derivatives 100
New potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases 99
[3H]HEMADO – a novel tritiated agonist selective for the human adenosine A(3) receptor 98
2-phenylhydroxypropynyladenosine derivatives as high potent agonists at A(2B) adenosine receptor subtype 97
2- And 8-alkynyl-9-ethyladenines: Synthesis and biological activity at human and rat adenosines receptors 97
Highlights on the development of A(2A) adenosine receptor agonists and antagonists 97
Synthesis and biological evaluation of 2-alkynyl-N6-methyl-5'-N-methylcarboxamidoadenosine derivatives as potent and highly selective agonists for the human adenosine A(3) receptor 96
Synthetic procedure for the preparation of novel potent and selective A(3) adenosine receptor radioligands 93
Purinergic P2X receptors: Structural models and analysis of receptor-ligand interaction 92
Synthesis and biological activity of trisubstituted adenines as A(2A) adenosine receptor antagonists 91
Functional cAMP assay optimization at CHO cells expressing A2A adenosine receptors and stably transfected with firefly luciferase biosensor 86
Deaza- and deoxyadenosine derivatives: synthesis and inhibition of animal viruses as human infectious models 85
Development of new chromatographic tools based on Adenosine A2A subtype receptor for ligand characterization and screening by FAC-MS 85
9-Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution result in distinct selectivities. 84
Sintesi di analoghi del paclitaxel vincolati conformazionalmente 83
Synthesis, Characterization, and Biological Activity of Purine and Pyrimidine Nucleoside and Nucleotide Analogues 83
Totale 14.414
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.546
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.933 0 0 340 668 209 301 250 333 231 230 122 249
2020/20213.158 127 253 179 241 161 376 627 71 277 155 436 255
2021/20221.637 185 414 34 40 77 80 94 127 123 176 110 177
2022/20231.798 202 120 45 303 176 256 9 106 315 104 110 52
2023/20241.398 187 79 95 63 65 125 55 90 162 38 41 398
2024/2025301 189 112 0 0 0 0 0 0 0 0 0 0
Totale 16.403